180 related articles for article (PubMed ID: 24530354)
21. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels.
Uno S; Dalton TP; Shertzer HG; Genter MB; Warshawsky D; Talaska G; Nebert DW
Biochem Biophys Res Commun; 2001 Dec; 289(5):1049-56. PubMed ID: 11741297
[TBL] [Abstract][Full Text] [Related]
22. Activation and detoxification metabolism of urban air pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone by rat and mouse hepatic microsomes.
Stiborova M; Cechova T; Borek-Dohalska L; Moserova M; Frei E; Schmeiser HH; Paca J; Arlt VM
Neuro Endocrinol Lett; 2012; 33 Suppl 3():8-15. PubMed ID: 23353838
[TBL] [Abstract][Full Text] [Related]
23. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
24. Effect of low-level short-term o-xylene inhalation of benzo[a]pyrene (BaP) metabolism and BaP-DNA adduct formation in rat liver and lung microsomes.
Park SH; Schatz RA
J Toxicol Environ Health A; 1999 Nov; 58(5):299-312. PubMed ID: 10598955
[TBL] [Abstract][Full Text] [Related]
25. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats.
Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM
Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501
[TBL] [Abstract][Full Text] [Related]
26. Comparative metabolism and excretion of benzo(a)pyrene in 2 species of ictalurid catfish.
Willett KL; Gardinali PR; Lienesch LA; Di Giulio RT
Toxicol Sci; 2000 Nov; 58(1):68-76. PubMed ID: 11053542
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Catalase Enhances Benzo(a)pyrene Detoxification in Endothelial Microsomes.
Yang F; Yang H; Ramesh A; Goodwin JS; Okoro EU; Guo Z
PLoS One; 2016; 11(9):e0162561. PubMed ID: 27607467
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
29. Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2.
Aimová D; Poljaková J; Kotrbová V; Moserová M; Frei E; Arlt VM; Stiborová M
Interdiscip Toxicol; 2008 Sep; 1(2):160-8. PubMed ID: 21218107
[TBL] [Abstract][Full Text] [Related]
30. Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta.
Uno S; Sakurai K; Nebert DW; Makishima M
Toxicology; 2014 Feb; 316():34-42. PubMed ID: 24394547
[TBL] [Abstract][Full Text] [Related]
31. Suppressive effect of 1-nitropyrene on benzo[a]pyrene-induced CYP1A1 protein expression in HepG2 cells.
Cherng SH; Hsu SL; Yang JL; Yu CT; Lee H
Toxicol Lett; 2006 Mar; 161(3):236-43. PubMed ID: 16280210
[TBL] [Abstract][Full Text] [Related]
32. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
Shiizaki K; Kawanishi M; Yagi T
Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
[TBL] [Abstract][Full Text] [Related]
33. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
Takemura H; Nagayoshi H; Matsuda T; Sakakibara H; Morita M; Matsui A; Ohura T; Shimoi K
Toxicology; 2010; 274(1-3):42-8. PubMed ID: 20553787
[TBL] [Abstract][Full Text] [Related]
35. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
Stiborová M; Frei E; Wiessler M; Schmeiser HH
Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary Inflammation Impacts on CYP1A1-Mediated Respiratory Tract DNA Damage Induced by the Carcinogenic Air Pollutant Benzo[a]pyrene.
Arlt VM; Krais AM; Godschalk RW; Riffo-Vasquez Y; Mrizova I; Roufosse CA; Corbin C; Shi Q; Frei E; Stiborova M; van Schooten FJ; Phillips DH; Spina D
Toxicol Sci; 2015 Aug; 146(2):213-25. PubMed ID: 25911668
[TBL] [Abstract][Full Text] [Related]
37. Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5.
Stiborová M; Poljaková J; Martínková E; Ulrichová J; Simánek V; Dvořák Z; Frei E
Toxicology; 2012 Dec; 302(2-3):233-41. PubMed ID: 22917556
[TBL] [Abstract][Full Text] [Related]
38. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation.
Uno S; Dalton TP; Derkenne S; Curran CP; Miller ML; Shertzer HG; Nebert DW
Mol Pharmacol; 2004 May; 65(5):1225-37. PubMed ID: 15102951
[TBL] [Abstract][Full Text] [Related]
39. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo[a]pyrene activation.
Gautier JC; Urban P; Beaune P; Pompon D
Eur J Biochem; 1993 Jan; 211(1-2):63-72. PubMed ID: 8425552
[TBL] [Abstract][Full Text] [Related]
40. Effect of hepatic cytochrome P450 (P450) oxidoreductase deficiency on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct formation in P450 reductase conditional null mice.
Arlt VM; Singh R; Stiborová M; Gamboa da Costa G; Frei E; Evans JD; Farmer PB; Wolf CR; Henderson CJ; Phillips DH
Drug Metab Dispos; 2011 Dec; 39(12):2169-73. PubMed ID: 21940903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
